Compare NetApp Inc. (NTAP) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetApp Inc. vs Regeneron Pharmaceuticals Inc — how do they compare? NetApp Inc. trades at $166.94 (market cap $31.57B), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 2.2× NetApp Inc.'s market cap, and NetApp Inc. pays the higher dividend (1.29%). Which is the better fit depends on your goals.
| NTAP | REGN | |
|---|---|---|
Market Cap | $31.57B | $70.47B |
Sector | Technology | Health |
52-Week High | $181.08 | $812.27 |
52-Week Low | $94.11 | $545.46 |
Enterprise Value | $30.72B | $64.42B |
Dividend Yield | 1.29% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
